Articles |
From Pennington Biomedical Research Center, Baton Rouge, La (M.L.); the Department of Medicine, Columbia University College of Physicians and Surgeons, New York, NY (H.N.G., R. Ramakrishnan); the Nutrition Department, Pennsylvania State University, University Park (P.M.K.-E., J.D.); the Division of Epidemiology, University of Minnesota School of Public Health, Minneapolis (P.J.E.); the Department of Biostatistics, Collaborative Studies Coordinating Center, The University of North Carolina at Chapel Hill (P.W.S.); the Division of Heart and Vascular Diseases, NHLBI, National Institutes of Health, Bethesda, Md (A.E., D.J.G.); the Research Institute, Mary Imogene Bassett Hospital, Cooperstown, NY (T.A.P., R. Reed); and the Department of Physiology, Louisiana State University Medical Center, New Orleans (P.S.R.).
Correspondence to Michael Lefevre, Pennington Biomedical Research Center, 6400 Perkins Rd, Baton Rouge, LA 70808-4124. E-mail lefevrm{at}mhs.pbrc.edu
Abstract Recent studies have suggested that variations in apoE genotypes may influence the magnitude of plasma lipid changes in response to dietary interventions. We examined the ability of apoE genotype to predict plasma lipid response to reductions in percent of calories from total fat (TF) and saturated fat (SF) in a normolipidemic study population (n=103) heterogeneous with respect to age, gender, race, and menopausal status. Three diets, an average American diet (34.3% TF, 15.0% SF), an AHA Step 1 diet (28.6% TF, 9.0% SF), and a low saturated fat (Low-Sat) diet (25.3% TF, 6.1% SF) were each fed for a period of 8 weeks in a three-way crossover design. Cholesterol was kept constant at 275 mg/d; monounsaturated and polyunsaturated fat were kept constant at approximately 13% and 6.5% of calories, respectively. Fasting lipid levels were measured during each of the final 4 weeks of each diet period. Participants were grouped by apoE genotype: E2 (E2/2, E2/3, E2/4); E3 (E3/3); E4 (E3/4, E4/4). Relative to the average American diet, both the Step 1 and Low-Sat diets significantly reduced total cholesterol, LDL cholesterol, and HDL cholesterol in all three apoE genotype groups. No evidence of a significant diet by genotype interaction, however, could be identified for any of the measured lipid and lipoprotein end points. Additional analysis of the data within individual population subgroups (men and women, blacks and whites) likewise provided no evidence of a significant diet by genotype interaction. Thus, in a heterogeneous, normolipidemic study population, apoE genotype does not predict the magnitude of lipid response to reductions in dietary saturated fat.
Key Words: dietary saturated fat step 1 diet apoE genotype
This article has been cited by other articles:
![]() |
M. Saito, M. Eto, H. Nitta, Y. Kanda, M. Shigeto, K. Nakayama, K. Tawaramoto, F. Kawasaki, S. Kamei, K. Kohara, et al. Effect of Apolipoprotein E4 Allele on Plasma LDL Cholesterol Response to Diet Therapy in Type 2 Diabetic Patients Diabetes Care, June 1, 2004; 27(6): 1276 - 1280. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. F Masson, G. McNeill, and A. Avenell Genetic variation and the lipid response to dietary intervention: a systematic review Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1098 - 1111. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Lehtimaki, P. Dastidar, H. Jokela, T. Koivula, S. Lehtinen, C. Ehnholm, and R. Punnonen Effect of Long-Term Hormone Replacement Therapy on Atherosclerosis Progression in Postmenopausal Women Relates to Functional Apolipoprotein E Genotype J. Clin. Endocrinol. Metab., September 1, 2002; 87(9): 4147 - 4153. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Eichner, S. T. Dunn, G. Perveen, D. M. Thompson, K. E. Stewart, and B. C. Stroehla Apolipoprotein E Polymorphism and Cardiovascular Disease: A HuGE Review Am. J. Epidemiol., March 15, 2002; 155(6): 487 - 495. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Corella, K. Tucker, C. Lahoz, O. Coltell, L A. Cupples, P. W. Wilson, E. J Schaefer, and J. M Ordovas Alcohol drinking determines the effect of the APOE locus on LDL-cholesterol concentrations in men: the Framingham Offspring Study Am. J. Clinical Nutrition, April 1, 2001; 73(4): 736 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. T Erkkila, E. S Sarkkinen, V. Lindi, S. Lehto, M. Laakso, and M. I. Uusitupa APOE polymorphism and the hypertriglyceridemic effect of dietary sucrose Am. J. Clinical Nutrition, April 1, 2001; 73(4): 746 - 752. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Ballantyne, J. A. Herd, E. A. Stein, L. L. Ferlic, J. K. Dunn, A. M. Gotto Jr., and A. J. Marian Apolipoprotein E genotypes and response of plasma lipids and progression-regression of coronary atherosclerosis to lipid-lowering drug therapy J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1572 - 1578. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Heikkinen, L. Niskanen, M. Ryynanen, M. H. Komulainen, M. T. Tuppurainen, M. Parviainen, and S. Saarikoski Is the Response of Serum Lipids and Lipoproteins to Postmenopausal Hormone Replacement Therapy Modified by ApoE Genotype? Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 402 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. N. Ginsberg, P. Kris-Etherton, B. Dennis, P. J. Elmer, A. Ershow, M. Lefevre, T. Pearson, P. Roheim, R. Ramakrishnan, R. Reed, et al. Effects of Reducing Dietary Saturated Fatty Acids on Plasma Lipids and Lipoproteins in Healthy Subjects : The Delta Study, Protocol 1 Arterioscler Thromb Vasc Biol, March 1, 1998; 18(3): 441 - 449. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1997 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |